OABI - OmniAb, Inc.
IEX Last Trade
3.53
-0.010 -0.283%
Share volume: 41,372
Last Updated: Thu 26 Dec 2024 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$3.54
-0.01
-0.28%
Fundamental analysis
20%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
30%
Performance
5 Days
1.15%
1 Month
-6.61%
3 Months
-16.55%
6 Months
-9.02%
1 Year
-42.41%
2 Year
-4.85%
Key data
Stock price
$3.53
DAY RANGE
$3.49 - $3.57
52 WEEK RANGE
$3.55 - $6.72
52 WEEK CHANGE
-$42.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Matthew W. Foehr
Region: US
Website: N/A
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: N/A
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Avista Public Acquisition Corp. II does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization or similar business combination. The company focuses on pursuing businesses in the healthcare industry.
Recent news